GlassScriptPhysician profile
Paul Michael Pearce
NPI 1902032600
$1,800.67
in general payments reported to CMS, 2019-2025
14 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $34.21 · 2021: $130 · 2022: $410 · 2023: $411 · 2024: $436 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $599.00 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $252.49 | 2024 | Ovitex 2s |
| Abbvie INC. | $213.31 | 2023-2025 | |
| Mentor Worldwide LLC | $192.04 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $136.83 | 2021-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Allergan, INC. | $97.23 | 2019 | |
| Galderma Laboratories, L.P. | $93.41 | 2019-2023 | |
| Kerecis Limited | $86.97 | 2022 | |
| Stryker Corporation | $31.41 | 2019 | |
| Acera Surgical, INC. | $28.52 | 2024-2025 | Restrata Wound Matrix |
| Acell, INC. | $25.37 | 2019-2020 | |
| Sientra, INC. | $17.53 | 2022 | |
| Lumenis, INC | $14.26 | 2021 | |
| Polynovo North America LLC | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.